PEG-g-poly(aspartamide-co-N, N-dimethylethylenediamino aspartamide): Synthesis, characterization and its application as a drug delivery system

Progress in Natural Science

Volumn 19, Issue 10, 2009, Pages 1305-1310

  Yang, Dong ^a   Zhang, Xiaohong ^a   Yuan, Li ^a   Hu, Jianhua ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Ammonium glycyrrhizinate; Drug delivery system; PEG g poly(aspartamide co N, N dimethylethylenediamino aspartamide); Polymeric micelle

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; DYNAMIC LIGHT SCATTERING; ENCAPSULATION; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MICELLES; SOLUTIONS; TARGETED DRUG DELIVERY;

AMMONIUM GLYCYRRHIZINATE; DRUG-DELIVERY SYSTEMS; ITS APPLICATIONS; METHOXY; PEG-G-POLY(ASPARTAMIDE-CO-N, N-DIMETHYLETHYLENEDIAMINO ASPARTAMIDE); POLY(ETHYLENE GLYCOL); POLYMERIC MICELLE; POLYSUCCINIMIDE; RING OPENING REACTION; SYNTHESISED;

POLYETHYLENE GLYCOLS;

EID: 70350621893     PISSN: 10020071     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnsc.2009.02.008     Document Type: Article

References (19)

1. Frankel M, Berger A. Synthesis of poly-aspartic acid. Nature 1949; 163: 213-4.
2. Xiong XB, Mahmud A, Uludag H, et al. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. Biomacromolecules 2007; 8: 874-84.
3. Nakato T, Yoshitake M, Matsubara K, et al. Relationships between structure and properties of poly(aspartic acid)s. Macromolecules 1998; 31: 2107-13.
4. Shogren RL, Willett JL, Westmoreland D, et al. Properties of copolymers of aspartic acid and aliphatic dicarboxylic acids prepared by reactive extrusion. J Appl Polym Sci 2008; 110: 3348-54.
5. Yan-Ming W, Zhang ZF, Yu Q, et al. Properties of poly[L-(aspartic acid)-co-L-lysine] grafted with cholesterol conjugated low molecular weight poly(ethylenimine) for gene delivery. Chem J Chin Univ 2008; 39: 2011-4.
6. Kakizawa Y, Miyata K, Furukawa S, et al. Size-controlled formation of a calcium phosphate-based organic-inorganic hybrid vector for gene delivery using poly(ethylene glycol)-block-poly(aspartic acid). Adv Mater 2004; 16: 699-702.
7. Jiang TY, Wang ZY, Chen C, et al. Poly(aspartic-acid) derivatives as polymeric micelle drug delivery systems. J Appl Polym Sci 2006; 101: 2871-8.
8. Wang Y, Wang YN, Wu GL, et al. pH-responsive self-assembly and conformational transition of partially propyl-esterified poly(alpha, beta-l-aspartic acid) as amphiphilic biodegradable polyanion. Colloids Surf B Biointerfaces 2009; 68: 13-9.
9. Chen HR, Xu W, Chen TY, et al. Aggregation of biodegradable amphiphilic poly(succinimide-co-N-propyl aspartamide) and poly(N-dodecyl aspartamide-co-N-propyl aspartamide) in aqueous medium and its preliminary drug-released properties. Polymer 2005; 46: 1821-7.
10. Xu W, Li L, Yang WL, et al. Amphiphilic hexylamine modified polysuccinimide: synthesis, characterization, and formation of nano-particles in aqueous medium. J Macromol Sci Pure Appl Chem 2003; A40: 511-23.
11. Chen W, Chen HR, Hu JH, et al. Synthesis and characterization of polyion complex micelles between poly(ethylene glycol)-grafted poly(aspartic acid) and cetyltrimethyl ammonium bromide. Colloids Surf Physicochem Eng Aspects 2006; 278: 60-6.
12. Ploeger B, Mensinga T, Sips A, et al. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev 2001; 33: 125-47.
13. Kimura M, Moro T, Okamoto H, et al. In vivo glycyrrhizin accelerates liver regeneration and rapidly lowers serum transaminase activities in 70% partially hepatectomized rats. J Pharm Sci 2008; 106: 257P.
14. Kumada H. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology 2002; 62: 94-100.
15. Nakata N, Kira Y, Yabunaka Y, et al. Prevention of venous thrombosis by preoperative glycyrrhizin infusion in a rat model. J Orthop Sci 2008; 13: 456-62.
16. Savic R, Eisenberg A, Maysinger D. Block copolymer micelles as delivery vehicles of hydrophobic drugs: micelle-cell interactions. J Drug Target 2006; 14: 343-55.
17. Aliabadi HM, Shahin M, Brocks DR, et al. Disposition of drugs in block copolymer micelle delivery systems-from discovery to recovery. Clin Pharmacokinet 2008; 47: 619-34.
18. Humpolickova J, Prochazka K, Hof M, et al. Fluorescence correlation spectroscopy using octadecylrhodamine B as a specific micelle-binding fluorescent tag; light scattering and tapping mode atomic force microscopy studies of amphiphilic water-soluble block copolymer micelles. Langmuir 2003; 19: 4111-9.
19. Zheng YL, Wu W, Yang WL, et al. Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles. J Pharm Sci 2006; 95: 181-91.